Cited by 477BRCA gene mutations in cancerBreast Lesions and CarcinomasDNA Repair Mechanisms

The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.

Ten Genes for Inherited Breast Cancer

Open access

Walsh, Tom, King, Mary-Claire·2007·Cancer Cell

DOI 10.1016/j.ccr.2007.01.010

Open this paper in CoChat — free account Open PDF

Abstract

Inherited breast cancer is associated with germline mutations in ten different genes in pathways critical to genomic integrity. BRCA1 and BRCA2 mutations confer very high risks of breast and ovarian cancer. p53 and PTEN mutations lead to very high breast cancer risks associated with rare cancer syndromes. Mutations in CHEK2, ATM, NBS1, RAD50, BRIP1, and PALB2 are associated with doubling of breast cancer risks. In addition, biallelic mutations in BRCA2, BRIP1, and PALB2 cause Fanconi anemia. The convergence of these genes in a shared role reveals underlying biology of these illnesses and suggests still other breast cancer genes.

Integrity signals

Registry

Crossref · 10.1016/j.ccr.2007.01.010

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Biallelic Inactivation of BRCA2 in Fanconi Anemia
Howlett, N. G., Taniguchi, T., Olson, S., Cox, B., Waisfisz, Q., de Die-Smulders, C., Persky, N., Grompe, M., Joenje, H., Pals, G., et al. (2002) · Science · doi:10.1126/science.1073834 · Cited by 1,149
Low-penetrance susceptibility to breast cancer due to CHEK2*1100delC in noncarriers of BRCA1 or BRCA2 mutations
The CHEK2-Breast Cancer Consortium (2002) · Nature Genetics · doi:10.1038/ng879 · Cited by 1,104
PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene
Rahman, N., Seal, S., Thompson, D. J., Kelly, P. F., Renwick, A., Elliott, A., Reid, S., Spanova, K., Barfoot, R., Chagtai, T., et al. (2006) · Nature Genetics · doi:10.1038/ng1959 · Cited by 1,026
Essential role for nuclear PTEN in maintaining chromosomal integrity
Shen, W. H., Balajee, A. S., Wang, J., Wu, H., Eng, C., Pandolfi, P. P., & Yin, Y. (2007) · Cell · doi:10.1016/j.cell.2006.11.042 · Cited by 979
Control of BRCA2 Cellular and Clinical Functions by a Nuclear Partner, PALB2
Xia, B., Sheng, Q., Nakanishi, K., Ohashi, A., Wu, J., Christ, N., Liu, X., Jasin, M., Couch, F. J., & Livingston, D. M. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.05.022 · Cited by 861
ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles
Renwick, A., Thompson, D. J., Seal, S., Kelly, P. F., Chagtai, T., Ahmed, M., North, B. V., Jayatilake, H., Barfoot, R., Spanova, K., et al. (2006) · Nature Genetics · doi:10.1038/ng1837 · Cited by 770
Truncating mutations in the Fanconi anemia J gene BRIP1 are low-penetrance breast cancer susceptibility alleles
The Breast Cancer Susceptibility Collaboration (UK), Seal, S., Thompson, D., Renwick, A., Elliott, A., Kelly, P., Barfoot, R., Chagtai, T., Jayatilake, H., Ahmed, M., et al. (2006) · Nature Genetics · doi:10.1038/ng1902 · Cited by 746
Spectrum of Mutations in BRCA1, BRCA2, CHEK2, and TP53 in Families at High Risk of Breast Cancer
Walsh, T., Casadei, S., Coats, K. H., Swisher, E. M., Stray, S. M., Higgins, J., Roach, K. C., Mandell, J. B., Lee, M. K., Čierniková, S., et al. (2006) · JAMA · doi:10.1001/jama.295.12.1379 · Cited by 673
Self-citation
Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer
Reid, S., Schindler, D., Hanenberg, H., Barker, K., Hanks, S., Kalb, R., Neveling, K., Kelly, P., Seal, S., Freund, M., et al. (2007) · Nature Genetics · doi:10.1038/ng1947 · Cited by 642
A recurrent mutation in PALB2 in Finnish cancer families
Erkko, H., Xia, B., Nikkilä, J., Schleutker, J., Syrjäkoski, K., Mannermaa, A., Kallioniemi, A. H., Pylkäs, K., Karppinen, S., Rapakko, K., et al. (2007) · Nature · doi:10.1038/nature05609 · Cited by 471

Flagged first, then by citations

Show all 15 references

Research works printed but not linked: 4

Erkko, 2007, Nature
Rahman, 2006, Nat. Genet.
Reid, 2006, Nat. Genet.
Xia, 2006, Nat. Genet.

Sorted by citations

Items 101–200 of 469

Drug Development for Cancer Chemoprevention: Focus on Molecular Targets
Johnson, K. A., & Brown, P. H. (2010) · Seminars in Oncology · doi:10.1053/j.seminoncol.2010.05.012 · Cited by 53
Targeting DNA repair in breast cancer: A clinical and translational update
Amir, E., Šeruga, B., Serrano, R., & Ocaña, A. (2010) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2010.03.006 · Cited by 52
Risk of having BRCA1 mutation in high‐risk women with triple‐negative breast cancer: a meta‐analysis
Tun, N. M., Villani, G. M., Ong, K., Yoe, L., & Bo, Z. (2013) · Clinical Genetics · doi:10.1111/cge.12270 · Cited by 52
PALB2 sequence variants in young South African breast cancer patients
Sluiter, M. D., Mynhardt, S., & van Rensburg, E. J. (2009) · Familial Cancer · doi:10.1007/s10689-009-9241-0 · Cited by 54
Comprehensive association testing of common genetic variation in DNA repair pathway genes in relationship with breast cancer risk in multiple populations
Haiman, C. A., Hsu, C., de Bakker, P. I. W., Frasco, M. A., Sheng, X., Berg, D. V. D., Casagrande, J. T., Kolonel, L. N., Marchand, L. L., Hankinson, S. E., et al. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm354 · Cited by 56
EMSY overexpression disrupts the BRCA2/RAD51 pathway in the DNA-damage response: implications for chromosomal instability/recombination syndromes as checkpoint diseases
Cousineau, I., & Belmaaza, A. (2011) · Molecular Genetics and Genomics · doi:10.1007/s00438-011-0612-5 · Cited by 57
Identification of genetic variation in 11 candidate genes of canine mammary tumour
Borge, K. S., Børresen‐Dale, A., & Lingaas, F. (2011) · Veterinary and Comparative Oncology · doi:10.1111/j.1476-5829.2010.00250.x · Cited by 54
Analysis of PALB2 Gene in BRCA1/BRCA2 Negative Spanish Hereditary Breast/Ovarian Cancer Families with Pancreatic Cancer Cases
Blanco, A., de la Hoya, M., Osório, A., Dı́ez, O., Miramar, M. D., Infante, M., Martínez-Bouzas, C., Torres, A., Lasa, A., Llort, G., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0067538 · Cited by 54
RAD51C germline mutations in breast and ovarian cancer patients
Akbari, M. R., Tonin, P. N., Foulkes, W. D., Ghadirian, P., Tischkowitz, M. D., & Narod, S. A. (2010) · Breast Cancer Research · doi:10.1186/bcr2619 · Cited by 55
A novel interplay between the Fanconi anemia core complex and ATR-ATRIP kinase during DNA cross-link repair
Tomida, J., Itaya, A., Shigechi, T., Unno, J., Uchida, E., Ikura, M., Masuda, Y., Matsuda, S., Adachi, J., Kobayashi, M., et al. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt467 · Cited by 53
A Finnish founder mutation in RAD51D: analysis in breast, ovarian, prostate, and colorectal cancer: Table 1
Pelttari, L. M., Kiiski, J. I., Nurminen, R., Kallioniemi, A. H., Schleutker, J., Gylfe, A. E., Aaltonen, L. A., Leminen, A., Heikkilä, P., BLOMQVIST, C. P., et al. (2012) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2012-100852 · Cited by 49
Association of DNA repair genes polymorphisms and mutations with increased risk of head and neck cancer: a review
Dylawerska, A., Barczak, W., Wegner, A., Golusiński, W., & Suchorska, W. M. (2017) · Medical Oncology · doi:10.1007/s12032-017-1057-4 · Cited by 52
Cancer evolution and individual susceptibility
Pérez‐Losada, J., Castellanos‐Martín, A., & Mao, J. (2011) · Integrative Biology · doi:10.1039/c0ib00094a · Cited by 49
Genetic Tests to Identify Risk for Breast Cancer
Lynch, J. A., Venne, V. L., & Berse, B. (2015) · Seminars in Oncology Nursing · doi:10.1016/j.soncn.2015.02.007 · Cited by 48
Identification of a Comprehensive Spectrum of Genetic Factors for Hereditary Breast Cancer in a Chinese Population by Next-Generation Sequencing
Yang, X., Wu, J., Lu, J., Liu, G., Di, G., Chen, C., Hou, Y., Sun, M., Yang, W., Xu, X., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0125571 · Cited by 47
Dulxanthone A induces cell cycle arrest and apoptosis via up‐regulation of p53 through mitochondrial pathway in HepG2 cells
Tian, Z., Shen, J., Moseman, A. P., Yang, Q., Yang, J., Xiao, P., Wu, E., & Kohane, I. S. (2007) · International Journal of Cancer · doi:10.1002/ijc.23048 · Cited by 47
Nasopharyngeal Carcinoma
Lung, M. L., Dai, W., & Ko, J. M. Y. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814936-2.00002-x · Cited by 46
The human nucleoporin Tpr protects cells from RNA-mediated replication stress
Košař, M., Giannattasio, M., Piccini, D., Maya‐Mendoza, A., García-Benítez, F., Bártková, J., Barroso, S. I., Gaillard, H., Martini, E., Restuccia, U., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-24224-3 · Cited by 51
Function and mechanism by which interferon regulatory factor-1 inhibits oncogenesis
Chen, F., Jiang, G., Xu, K., & Zheng, J. (2012) · Oncology Letters · doi:10.3892/ol.2012.1051 · Cited by 46
Evaluation of Therapeutic Potential of Eugenol-A Natural Derivative of Syzygium aromaticum on Cervical Cancer
Das, A., Harshadha, K., K, D. K. S., Hari Raj, K., & Jayaprakash, B. (2018) · Europe PMC (PubMed Central) · doi:10.22034/apjcp.2018.19.7.1977 · Cited by 45
Identification of novel common breast cancer risk variants at the 6q25 locus among Latinas
Hoffman, J., Fejerman, L., Hu, D., Huntsman, S., Li, M., John, E. M., Torres-Mejı́a, G., Kushi, L., Ding, Y. C., Weitzel, J. N., et al. (2019) · Breast Cancer Research · doi:10.1186/s13058-018-1085-9 · Cited by 46
New pathway links from cancer‐progression determinants to gene expression of matrix metalloproteinases in breast cancer cells
DeLassus, G. S., Cho, H., Park, J., & Eliceiri, G. L. (2008) · Journal of Cellular Physiology · doi:10.1002/jcp.21548 · Cited by 45
Detection and precise mapping of germline rearrangements in BRCA1, BRCA2, MSH2, and MLH1 using zoom-in array comparative genomic hybridization (aCGH)
Staaf, J., Törngren, T., Rambech, E., Johansson, U., Persson, C., Sellberg, G., Tellhed, L., Nilbert, M., & Borg, Å. (2008) · Human Mutation · doi:10.1002/humu.20678 · Cited by 44
BRCA1 Pathway Function in Basal-Like Breast Cancer Cells
Hill, S. J., Clark, A. P., Silver, D. P., & Livingston, D. M. (2014) · Molecular and Cellular Biology · doi:10.1128/mcb.01646-13 · Cited by 44
Loss of p53 partially rescues embryonic development of Palb2 knockout mice but does not foster haploinsufficiency of Palb2 in tumour suppression
Bouwman, P., Drost, R., Klijn, C. N., Pieterse, M., van der Gulden, H. M. L., Song, J., Szuhai, K., & Jonkers, J. (2011) · The Journal of Pathology · doi:10.1002/path.2861 · Cited by 47
Robust homology-directed repair within mouse mammary tissue is not specifically affected by Brca2 mutation
Kass, E. M., Lim, P. X., Helgadottir, H. R., Moynahan, M. E., & Jasin, M. (2016) · Nature Communications · doi:10.1038/ncomms13241 · Cited by 45
Greek BRCA1 and BRCA2 mutation spectrum: two BRCA1 mutations account for half the carriers found among high-risk breast/ovarian cancer patients
Konstantopoulou, I., Rampias, T., Ladopoulou, A., Koutsodontis, G., Armaou, S., Anagnostopoulos, T., Nikolopoulos, G., Kamakari, S., Nounesis, G., Stylianakis, A., et al. (2007) · Breast Cancer Research and Treatment · doi:10.1007/s10549-007-9571-2 · Cited by 43
Hereditary breast cancer: beyond BRCA genetic analysis; PALB2 emerges
Πουμπουρίδου, Ν., & Κroupis, C. (2012) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2011-0840 · Cited by 43
Bcl-2 Inhibits Nuclear Homologous Recombination by Localizing BRCA1 to the Endomembranes
Laulier, C., Barascu, A., Guirouilh‐Barbat, J., Pennarun, G., Chalony, C. L., Chevalier, F., Palierne, G., Bertrand, P., Verbavatz, J., & López, B. S. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3119 · Cited by 49
Effect of astaxanthin and melatonin on cell viability and DNA damage in human breast cancer cell lines
Karimian, A., Mohammadrezaei, F. M., Moghaddam, A. H., Bahadori, M. H., Ghorbani-Anarkooli, M., Asadi, A., & Abdolmaleki, A. (2021) · Acta Histochemica · doi:10.1016/j.acthis.2021.151832 · Cited by 41
Next-generation sequencing applied to molecular diagnostics
Natrajan, R., & Reis-Filho, J. S. (2011) · Expert Review of Molecular Diagnostics · doi:10.1586/erm.11.18 · Cited by 41
Genetic variation in genes interacting with BRCA1/2 and risk of breast cancer in the Cypriot population
Loizidou, M. A., Cariolou, M. A., Neuhausen, S. L., Newbold, R. F., Bashiardes, E., Marcou, Y., Michael, T., Daniel, M., Kakouri, E., Papadopoulos, P., et al. (2009) · Breast Cancer Research and Treatment · doi:10.1007/s10549-009-0518-7 · Cited by 39
Contribution of BRCA1 germ-line mutations to breast cancer in Greece: a hospital-based study of 987 unselected breast cancer cases
Armaou, S., Pertesi, M., Fostira, F., Thodi, G., Athanasopoulos, P. S., Kamakari, S., Athanasiou, A. E., Gogas, H. J., Yannoukakos, D., Fountzilas, G., et al. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605115 · Cited by 39
Non-founder BRCA1 mutations in Russian breast cancer patients
Iyevleva, A. G., Suspitsin, E. N., Kroeze‐Jansema, K., Gorodnova, T. V., Соколенко, А. П., Buslov, K. G., Voskresenskiy, D. A., Togo, A. V., Коваленко, С. П., van der Stoep, N., et al. (2010) · Cancer Letters · doi:10.1016/j.canlet.2010.07.013 · Cited by 39
Clinical Management of Hereditary Breast Cancer Syndromes
Clark, A. S., & Domchek, S. M. (2011) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-011-9200-x · Cited by 38
Gene expression profiling assigns CHEK2 1100delC breast cancers to the luminal intrinsic subtypes
Nagel, J. H. A., Peeters, J. K., Smid, M., Sieuwerts, A. M., Wasielewski, M., de Weerd, V., Trapman-Jansen, A., van den Ouweland, A., Brüggenwirth, H. T., van IJcken, W. F. J., et al. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1588-x · Cited by 39
Significance of the Fanconi Anemia FANCD2 Protein in Sporadic and Metastatic Human Breast Cancer
Rudland, P. S., Platt-Higgins, A. M., Davies, L. M., Rudland, S. D. S., Wilson, J. B., Aladwani, A., Winstanley, J. H. R., Barraclough, D. L., Barraclough, R., West, C. R., et al. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.090779 · Cited by 38
The power of DNA double‐strand break (DSB) repair testing to predict breast cancer susceptibility
Keimling, M., Deniz, M., Varga, D., Stahl, A., Schrezenmeier, H., Kreienberg, R., Hoffmann, I., König, J., & Wiesmüller, L. (2012) · The FASEB Journal · doi:10.1096/fj.11-200790 · Cited by 38
Mutation analysis of BRIP1/BACH1 in BRCA1/BRCA2 negative Chinese women with early onset breast cancer or affected relatives
Cao, A.-Y., Huang, J., Hu, Z., Li, W.-F., Ma, Z.-L., Tang, L.-L., Zhang, B., Su, F.-X., Zhou, J., Di, G.-H., et al. (2009) · Breast Cancer Research and Treatment · doi:10.1007/s10549-008-0052-z · Cited by 37
BRCA1-mediated repression of mutagenic end-joining of DNA double-strand breaks requires complex formation with BACH1
Dohrn, L., Salles, D. C., Siehler, S. Y., Kaufmann, J., & Wiesmüller, L. (2011) · Biochemical Journal · doi:10.1042/bj20110314 · Cited by 41
FANCM mutation c.5791C>T is a risk factor for triple-negative breast cancer in the Finnish population
Kiiski, J. I., Tervasmäki, A., Pelttari, L. M., Khan, S., Mantere, T., Pylkäs, K., Mannermaa, A., Tengström, M., Kvist, A., Borg, Å., et al. (2017) · Breast Cancer Research and Treatment · doi:10.1007/s10549-017-4388-0 · Cited by 37
Genetic architecture of quantitative traits and complex diseases
Fu, W., O’Connor, T. D., & Akey, J. M. (2013) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2013.10.008 · Cited by 40
DNA-repair genetic polymorphisms and risk of breast cancer in Cyprus
Loizidou, M. A., Michael, T., Neuhausen, S. L., Newbold, R. F., Marcou, Y., Kakouri, E., Daniel, M., Papadopoulos, P., Malas, S., Hadjisavvas, A., et al. (2008) · Breast Cancer Research and Treatment · doi:10.1007/s10549-008-0084-4 · Cited by 37
AKT1/BRCA1 in the control of homologous recombination and genetic stability: the missing link between hereditary and sporadic breast cancers
Guirouilh‐Barbat, J., Wilhelm, T., & López, B. S. (2010) · Oncotarget · doi:10.18632/oncotarget.203 · Cited by 38
Analysis of large mutations in BARD1 in patients with breast and/or ovarian cancer: the Polish population as an example
Klonowska, K., Ratajska, M., Czubak, K., Kuźniacka, A., Brożek, I., Koczkowska, M., Śniadecki, M., Dębniak, J., Wydra, D. G., Balut, M., et al. (2015) · Scientific Reports · doi:10.1038/srep10424 · Cited by 36
Functional polymorphisms, altered gene expression and genetic association link NRH:quinone oxidoreductase 2 to breast cancer with wild-type p53
Yu, K., Di, G., Yuan, W., Fan, L., Wu, J., Hu, Z., Shen, Z., Zheng, Y., Huang, W., & Shao, Z.-M. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp171 · Cited by 38
The molecular genetics of breast cancer and targeted therapy.
Suter, R., & Marcum, J. A. (2007) · PubMed Central · Cited by 36
CHEK2 1100delC Is a Susceptibility Allele for HNPCC-Related Colorectal Cancer
Wasielewski, M., Vasen, H. F. A., Wijnen, J., Hooning, M. J., Dooijes, D., Tops, C. M. J., Klijn, J. G. M., Meijers-Heijboer, H. E. J., & Schutte, M. E. M. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0389 · Cited by 35
Low-risk susceptibility alleles in 40 human breast cancer cell lines
Riaz, M. A., Elstrodt, F., Hollestelle, A., Dehghan, A., Klijn, J. G. M., & Schutte, M. E. M. (2009) · BMC Cancer · doi:10.1186/1471-2407-9-236 · Cited by 36
Sequence variations of mitochondrial DNA D-loop region are highly frequent events in familial breast cancer
Yu, M., Shi, Y., Zhang, F., Zhou, Y., Yang, Y., Wei, X., Zhang, L., & Niu, R. (2007) · Journal of Biomedical Science · doi:10.1007/s11373-007-9229-4 · Cited by 35
Association of genetic variants at TOX3, 2q35 and 8q24 with the risk of familial and early-onset breast cancer in a South-American population
Elematore, I., González‐Hormazábal, P., Reyes, J. M., Blanco, R., Bravo, T., Peralta, O., Gómez, F., Waugh, E., Margarit, S., Ibañez, G., et al. (2014) · Molecular Biology Reports · doi:10.1007/s11033-014-3236-0 · Cited by 34
A portrait of germline mutation in Brazilian at-risk for hereditary breast cancer
Timóteo, A. R. D. S., Gonçalves, A. É. M. M., Sales, L. A. P., Albuquerque, B. M., de Souza, J. E. S., de Moura, P. C. P., de Aquino, M. A. A., Agnez‐Lima, L. F., & Lajus, T. B. P. (2018) · Breast Cancer Research and Treatment · doi:10.1007/s10549-018-4938-0 · Cited by 34
Heterozygous PALB2 c.1592delT mutation channels DNA double-strand break repair into error-prone pathways in breast cancer patients
Obermeier, K., Sachsenweger, J., Friedl, T. W. P., Pospiech, H., Winqvist, R., & Wiesmüller, L. (2015) · Oncogene · doi:10.1038/onc.2015.448 · Cited by 33
NBS1 variant I171V and breast cancer risk
Bogdanova, N. V., Schürmann, P., Waltes, R., Feshchenko, S., Zalutsky, I. V., Bremer, M., & Dörk, T. (2007) · Breast Cancer Research and Treatment · doi:10.1007/s10549-007-9820-4 · Cited by 34
RAD51C – A new human cancer susceptibility gene for sporadic squamous cell carcinoma of the head and neck (HNSCC)
Scheckenbach, K., Baldus, S. E., Balz, V., Freund, M., Pakropa, P., Sproll, C. K., Schäfer, K.-L., Wagenmann, M., Schipper, J. H., & Hanenberg, H. (2013) · Oral Oncology · doi:10.1016/j.oraloncology.2013.11.007 · Cited by 32
Hereditary breast cancer: from bench to bedside
Grève, J. D., Sermijn, E., Brakeleer, S. D., Ren, Z., & Teugels, E. (2008) · Current Opinion in Oncology · doi:10.1097/cco.0b013e3283139173 · Cited by 32
Joint Analysis of Multiple Traits Using "Optimal" Maximum Heritability Test
Wang, Z., Sha, Q., & Zhang, S. (2016) · PLoS ONE · doi:10.1371/journal.pone.0150975 · Cited by 32
DNA double-strand break repair activities in mammary epithelial cells--influence of endogenous p53 variants
Keimling, M., & Wiesmüller, L. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp117 · Cited by 32
Mammary cancer susceptibility: human genes and rodent models
Szpirer, C., & Szpirer, J. (2007) · Mammalian Genome · doi:10.1007/s00335-007-9073-x · Cited by 31
Low p53 Binding Protein 1 (53BP1) Expression Is Associated With Increased Local Recurrence in Breast Cancer Patients Treated With Breast-Conserving Surgery and Radiotherapy
Neboori, H. J., Haffty, B. G., Wu, H., Yang, Q., Aly, A., Goyal, S., Schiff, D. S., Moran, M. S., Golhar, R., Chen, C., et al. (2012) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2012.01.089 · Cited by 31
Evaluating genetic variants associated with breast cancer risk in high and moderate-penetrance genes in Asians
Han, M.-R., Zheng, W., Cai, Q., Gao, Y.-T., Zheng, Y., Bolla, M. K., Michailidou, K., Dennis, J., Wang, Q., Dunning, A. M., et al. (2017) · Carcinogenesis · doi:10.1093/carcin/bgx010 · Cited by 31
Full in-frame exon 3 skipping of BRCA2 confers high risk of breast and/or ovarian cancer
Caputo, S. M., French COVAR group collaborators, Léoné, M., Damiola, F., Ehlén, Å., Carreira, A., Gaidrat, P., Martins, A., Brandão, R. D., Peixoto, A., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.24671 · Cited by 34
Genetic variants in GSTM3 gene within GSTM4-GSTM2-GSTM1-GSTM5-GSTM3 cluster influence breast cancer susceptibility depending on GSTM1
Yu, K., Fan, L., Di, G., Yuan, W. T., Zheng, Y., Huang, W., Chen, A.-X., Yang, C., Wu, J., Shen, Z., et al. (2009) · Breast Cancer Research and Treatment · doi:10.1007/s10549-009-0585-9 · Cited by 31
Breast cancer in a case of Shwachman Diamond syndrome
Singh, S. A., Vlachos, A., Morgenstern, N. J., Ouansafi, I., Ip, W., Rommens, J. M., Durie, P. R., Shimamura, A., & Lipton, J. M. M. (2011) · Pediatric Blood & Cancer · doi:10.1002/pbc.24052 · Cited by 31
The Fanconi Family Adds a Fraternal Twin
Grompe, M., & van de Vrugt, H. (2007) · Developmental Cell · doi:10.1016/j.devcel.2007.04.008 · Cited by 31
Genetic variants in trinucleotide repeat-containing 9 (TNRC9) are associated with risk of estrogen receptor positive breast cancer in a Chinese population
Liang, J., Chen, P., Hu, Z., Shen, H., Wang, F., Chen, L., Li, M., Tang, J., Wang, H., & Shen, H. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-0809-z · Cited by 30
Adherence to NCCN Guidelines for Genetic Testing in Breast Cancer Patients: Who Are We Missing?
Alberty‐Oller, J. J., Weltz, S., dos Santos, A. G., Pisapati, K. V., Ru, M., Weltz, C., Schmidt, H., & Port, E. R. (2020) · Annals of Surgical Oncology · doi:10.1245/s10434-020-09123-z · Cited by 30
Mutation analysis of BRIP1 in male breast cancer cases: a population-based study in Central Italy
Silvestri, V., Rizzolo, P., Falchetti, M., Zanna, I., Masala, G., Bianchi, S., Palli, D., & Ottini, L. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-1289-x · Cited by 32
A fragile site within the HPC1 region at 1q25.3 affecting RGS16, RGSL1, and RGSL2 in human breast carcinomas
Wiecheć, E., Overgaard, J., & Hansen, L. L. (2008) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20578 · Cited by 30
SPLUNC1 Regulates Cell Progression and Apoptosis through the miR-141-PTEN/p27 Pathway, but Is Hindered by LMP1
Chen, P., Guo, X., Zhou, H., Zhang, W., Zeng, Z., Liao, Q., Li, X., Xiang, B., Yang, J., Ma, J., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056929 · Cited by 30
Assessing the link between BACH1/FANCJ and MLH1 in DNA crosslink repair
Cantor, S. B., & Xie, J. (2010) · Environmental and Molecular Mutagenesis · doi:10.1002/em.20568 · Cited by 29
Protein-truncating variants in moderate-risk breast cancer susceptibility genes: A meta-analysis of high-risk case-control screening studies
Aloraifi, F., McCartan, D. P., McDevitt, T., Green, A., Bracken, A. P., & Geraghty, J. (2015) · Cancer Genetics · doi:10.1016/j.cancergen.2015.06.001 · Cited by 30
The 30 kb deletion in the APOBEC3 cluster decreases APOBEC3A and APOBEC3B expression and creates a transcriptionally active hybrid gene but does not associate with breast cancer in the European population
Klonowska, K., Kluźniak, W., Rusak, B., Jakubowska, A., Ratajska, M., Krawczyńska, N., Vasilevska, D., Czubak, K., Wojciechowska, M., Cybulski, C., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.19400 · Cited by 29
Toll-like receptor 3 acts as a suppressor gene in breast cancer initiation and progression: a two-stage association study and functional investigation
Fan, L., Zhou, P., Qi, H., Chen, A.-X., Liu, G., Yu, K., & Shao, Z. (2019) · OncoImmunology · doi:10.1080/2162402x.2019.1593801 · Cited by 30
GOPC-ROS1 Fusion Due to Microdeletion at 6q22 Is an Oncogenic Driver in a Subset of Pediatric Gliomas and Glioneuronal Tumors
Richardson, T. E., Tang, K., Vasudevaraja, V., Serrano, J., William, C. M., Mirchia, K., Pierson, C. R., Leonard, J. R., Abdelbaki, M. S., Schieffer, K. M., et al. (2019) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlz093 · Cited by 29
The Saccharomyces cerevisiae RAD9, RAD17 and RAD24 genes are required for suppression of mutagenic post-replicative repair during chronic DNA damage
Murakami, A., Huang, D., Piening, B., Bangur, C. S., & Paulovich, A. G. (2010) · DNA repair · doi:10.1016/j.dnarep.2010.04.007 · Cited by 28
Genetic and epigenetic alterations in breast cancer: What are the perspectives for clinical practice?
Fucito, A., Lucchetti, C., Giordano, A., & Romano, G. (2007) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2007.10.018 · Cited by 29
A multidisciplinary clinic for individualizing management of patients at increased risk for breast and gynecologic cancer
Engel, N. J., Gordon, P., Thull, D. L., Dudley, B., Herstine, J., Jankowitz, R. C., & Zorn, K. K. (2012) · Familial Cancer · doi:10.1007/s10689-012-9530-x · Cited by 28
A novel recurrent CHEK2 Y390C mutation identified in high-risk Chinese breast cancer patients impairs its activity and is associated with increased breast cancer risk
Wang, N., Ding, H., Liu, C., Li, X., Wei, L., Yu, J., Liu, M., Ying, M., Gao, W., Jiang, H., et al. (2015) · Oncogene · doi:10.1038/onc.2014.443 · Cited by 28
Multigene pathway‐based analyses identify nasopharyngeal carcinoma risk associations for cumulative adverse effects of TERT‐CLPTM1L and DNA double‐strand breaks repair
Ko, J. M. Y., Dai, W., Wong, E. H. W., Kwong, D. L. �., Ng, W. T., Lee, A., Ngan, R. K., Yau, C. C., Tung, S. Y., & Lung, M. L. (2014) · International Journal of Cancer · doi:10.1002/ijc.28802 · Cited by 27
Prodigiosin-induced cytotoxicity involves RAD51 down-regulation through the JNK and p38 MAPK pathways in human breast carcinoma cell lines
Lu, C., Lin, S.-C., Yang, S.-Y., Pan, M., Lin, Y., Hsu, C., Wei, Y., Chang, J., & Chang, C. (2012) · Toxicology Letters · doi:10.1016/j.toxlet.2012.05.002 · Cited by 27
The DNA damage response - from cell biology to human disease
Lam, F. C. (2022) · Journal of Translational Genetics and Genomics · doi:10.20517/jtgg.2021.61 · Cited by 29
Transcriptional Responses to Estrogen and Progesterone in Mammary Gland Identify Networks Regulating p53 Activity
Lu, S., Becker, K. A., Hagen, M. J., Yan, H., Roberts, A. L., Mathews, L., Schneider, S. S., Siegelmann, H. T., MacBeth, K. J., Tirrell, S. M., et al. (2008) · Endocrinology · doi:10.1210/en.2008-0035 · Cited by 27
XRCC3 and RAD51 Expression Are Associated with Clinical Factors in Breast Cancer
Hu, J., Wang, N., & Wang, Y. (2013) · PLoS ONE · doi:10.1371/journal.pone.0072104 · Cited by 27
Cooperativity of Rb, Brca1, and p53 in Malignant Breast Cancer Evolution
Kumar, P., Mukherjee, M., Johnson, J. P. S., Patel, M., Huey, B., Albertson, D. G., & Simin, K. J. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1003027 · Cited by 27
Translational opportunities for broad‐spectrum natural phytochemicals and targeted agent combinations in breast cancer
Nagaprashantha, L. D., Adhikari, R., Singhal, J., Chikara, S., Awasthi, S., Horne, D. A., & Singhal, S. S. (2017) · International Journal of Cancer · doi:10.1002/ijc.31085 · Cited by 26
A sensitive test for the detection of specific DSB repair defects in primary cells from breast cancer specimens
Keimling, M., Kaur, J., Bagadi, S. A. R., Kreienberg, R., Wiesmüller, L., & Ralhan, R. (2008) · International Journal of Cancer · doi:10.1002/ijc.23551 · Cited by 27
Complex Landscape of Germline Variants in Brazilian Patients With Hereditary and Early Onset Breast Cancer
Torrezan, G. T., Almeida, F. G. S. R., Figueiredo, M. C., Barros, B. D. D. F., de Paula, C. A. A., Valieris, R., de Souza, J. E. S., Ramalho, R. F., da Silva, F. C. C., Ferreira, E. N., et al. (2018) · Frontiers in Genetics · doi:10.3389/fgene.2018.00161 · Cited by 25
Study on the Mechanism of Cell Cycle Checkpoint Kinase 2 (CHEK2) Gene Dysfunction in Chemotherapeutic Drug Resistance of Triple Negative Breast Cancer Cells
Luo, L., Gao, W., Wang, J., Wang, D., Peng, X., Jia, Z., Jiang, Y., Li, G., Tang, D., & Wang, Y. (2018) · Medical Science Monitor · doi:10.12659/msm.907256 · Cited by 25
A common nonsense mutation of the BLM gene and prostate cancer risk and survival
Antczak, A., Kluźniak, W., Wokołorczyk, D., Kashyap, A., Jakubowska, A., Gronwald, J., Huzarski, T., Byrski, T., Dębniak, T., Masojć, B., et al. (2013) · Gene · doi:10.1016/j.gene.2013.09.079 · Cited by 25
Evaluation of the BRCA1 interacting genes RAP80 and CCDC98 in familial breast cancer susceptibility
Osório, A., Barroso, A., García, M. J., Martínez–Delgado, B., Urioste, M., & Benitez, J. J. (2008) · Breast Cancer Research and Treatment · doi:10.1007/s10549-008-9933-4 · Cited by 27
Risk-Association of Five SNPs in TOX3/LOC643714 with Breast Cancer in Southern China
He, X., Yao, G., Li, F., Li, M., & Yang, X. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15022130 · Cited by 24
Rare germline large rearrangements in the BRCA1/2 genes and eight candidate genes in 472 patients with breast cancer predisposition
Rouleau, É., Jesson, B., Briaux, A., Noguès, C., Chabaud, V., Demange, L., Sokolowska, J., Coulet, F., Barouk-Simonet, E., Bignon, Y., et al. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-012-2009-5 · Cited by 24
Complex Breakpoints and Template Switching Associated with Non-canonical Termination of Homologous Recombination in Mammalian Cells
Hartlerode, A. J., Willis, N. A., Rajendran, A., Manis, J. P., & Scully, R. (2016) · PLoS Genetics · doi:10.1371/journal.pgen.1006410 · Cited by 24
PALB2 mutations in BRCA1/2-mutation negative breast and ovarian cancer patients from Poland
Kluska, A., Bałabas, A., Piątkowska, M., Czarny, K., Paczkowska, K., Nowakowska, D., Mikuła, M., & Ostrowski, J. (2017) · BMC Medical Genomics · doi:10.1186/s12920-017-0251-8 · Cited by 24
Genetic and molecular biology of breast cancer among Iranian patients
Moghbeli, M. (2019) · Journal of Translational Medicine · doi:10.1186/s12967-019-1968-2 · Cited by 25
Clinicopathological characteristics of gene-positive breast cancer in the United Arab Emirates
Altinoz, A., Ameri, M. A., Qureshi, W., Boush, N., Nair, S. C., & Abdel-Aziz, A. (2020) · The Breast · doi:10.1016/j.breast.2020.07.005 · Cited by 23
Cancer predisposing BARD1 mutations affect exon skipping and are associated with overexpression of specific BARD1 isoforms
Ratajska, M., Matusiak, M., Kuźniacka, A., Wasąg, B., Brożek, I., Biernat, W., Koczkowska, M., Dębniak, J., Śniadecki, M., Kozłowski, P., et al. (2015) · Oncology Reports · doi:10.3892/or.2015.4235 · Cited by 23
Ovarian Cancer: In Search of Better Marker Systems Based on DNA Repair Defects
Varga, D., Deniz, M., Schwentner, L., & Wiesmüller, L. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms14010640 · Cited by 23
Identification of a novel CHEK2variant and assessment of its contribution to the risk of breast cancer in French Canadian women
Novak, D. J., Chen, L. Q., Ghadirian, P., Hamel, N., Zhang, P., Rossiny, V., Cardinal, G., Robidoux, A., Tonin, P. N., Rousseau, F., et al. (2008) · BMC Cancer · doi:10.1186/1471-2407-8-239 · Cited by 24

Authors: Walsh, T., & King, M.-C.
Affiliations: University of Washington (US)
Corresponding author: Walsh, Tom
King, Mary-Claire
ORCID: Walsh, Tom
King, Mary-Claire
Venue: Cancer Cell
Publisher: Elsevier BV
Published: 2007-02
Volume: 11
Issue: 2
Pages: 103-105
ISSN: 1535-6108 (ISSN-L)
DOI: 10.1016/j.ccr.2007.01.010
OpenAlex: W2023353541
Cited by: 477
References: 15
Citations by year: 2026: 3 · 2025: 6 · 2024: 5 · 2023: 9 · 2022: 10 · 2021: 12 · 2020: 21 · 2019: 21 · 2018: 22 · 2017: 20 · 2016: 23 · 2015: 24 · 2014: 38 · 2013: 36 · 2012: 36
FWCI: 25.35
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/open-access/userlicense/1.0/ (vor, 2358 d)
Locations: Cancer Cell (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › BRCA gene mutations in cancer
Health Sciences › Medicine › Pathology and Forensic Medicine › Breast Lesions and Carcinomas
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
Keywords: hereditary breast cancer, germline mutations, BRCA1, BRCA2, p53, PTEN, CHEK2, ATM, NBS1, RAD50, BRIP1, PALB2, Fanconi anemia, genome stability, cancer susceptibility genes, ovarian cancer
MeSH terms: Fanconi Anemia Complementation Group N Protein, Breast Neoplasms, DNA-Binding Proteins, Fanconi Anemia, Humans, Neoplasm Proteins, Nuclear Proteins, Tumor Suppressor Protein p53, Protein Serine-Threonine Kinases, Acid Anhydride Hydrolases, Germ-Line Mutation, Cell Cycle Proteins, BRCA1 Protein, Genetic Predisposition to Disease, RNA Helicases, BRCA2 Protein, Tumor Suppressor Proteins, DNA Repair Enzymes, PTEN Phosphohydrolase, Fanconi Anemia Complementation Group Proteins, Ataxia Telangiectasia Mutated Proteins, Checkpoint Kinase 2

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Ten Genes for Inherited Breast Cancer

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks